Loading...
XWARMWT
Market cap1mUSD
Dec 23, Last price  
2.94PLN
1D
0.00%
Jan 2017
-71.87%
IPO
-37.58%
Name

MW Trade SA

Chart & Performance

D1W1MN
XWAR:MWT chart
P/E
—
P/S
10.55
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
-21.17%
Rev. gr., 5y
-51.90%
Revenues
711k
-44.58%
8,211,00010,626,00021,285,00016,363,00017,550,00025,797,00030,517,00032,962,00058,369,00040,865,00027,611,00013,071,0004,030,0001,791,0001,283,000711,000
Net income
-2m
L+28.60%
1,499,0003,069,0007,035,0009,008,0009,015,00014,046,00017,163,00019,401,00012,668,0007,770,0002,050,000-2,067,000-3,844,000-609,000-1,769,000-2,275,000
CFO
-691k
L
-5,065,000-2,720,000-39,522,000-29,672,000-96,686,000-112,038,00084,819,000-14,004,000102,053,00075,003,000117,758,000108,196,0004,608,00038,277,0002,731,000-691,000
Dividend
May 21, 20202.1 PLN/sh

Profile

M.W. Trade SA provides financial services for the health care sector in Poland and internationally. The company offers financial solutions for hospitals, including hospital fund for solving debt problems and difficulties connected with the financial liquidity of health care entities; and current funding for temporary cash-flow problems to cover the current transaction or investment projects for functioning. It also provides financing to solve temporary problems; and banking products, such as current accounts, working capital facilities, investment credit, leasing, bank deposits, and banking and investment products for employees of health care entities. In addition, the company offers financial solutions for suppliers that consist of transaction security and financing, investment financing, and banking products. It serves pharmaceutical companies, medical equipment manufacturers, and other local enterprises. The company was founded in 2004 and is based in Wroclaw, Poland. M.W. Trade SA is a subsidiary of Getin Holding SA.
URL
http://www.mwtrade.pl/
IPO date
Sep 28, 2007
Employees
7
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
711
-44.58%
1,283
-28.36%
1,791
-55.56%
Cost of revenue
3,109
2,911
3,402
Unusual Expense (Income)
NOPBT
(2,398)
(1,628)
(1,611)
NOPBT Margin
Operating Taxes
139
(35)
(926)
Tax Rate
NOPAT
(2,537)
(1,593)
(685)
Net income
(2,275)
28.60%
(1,769)
190.48%
(609)
-84.16%
Dividends
Dividend yield
Proceeds from repurchase of equity
(29,391)
BB yield
136.56%
Debt
Debt current
184
121
Long-term debt
1,172
1,261
Deferred revenue
7,386
Other long-term liabilities
(4,426)
5,727
Net debt
(18,928)
(28,932)
(60,702)
Cash flow
Cash from operating activities
(691)
2,731
38,277
CAPEX
(4,756)
(5)
(14)
Cash from investing activities
(3,778)
552
(14)
Cash from financing activities
8
(29,496)
(2,402)
FCF
(8,052)
(1,529)
(562)
Balance
Cash
19,326
28,090
56,475
Long term investments
958
2,224
4,227
Excess cash
20,248
30,250
60,612
Stockholders' equity
6,619
(7,372)
6,373
Invested Capital
21,207
40,372
59,863
ROIC
ROCE
EV
Common stock shares outstanding
2,553
4,869
8,384
Price
5.90
33.48%
4.42
-11.24%
4.98
173.63%
Market cap
15,060
-30.03%
21,522
-48.45%
41,755
173.63%
EV
(3,332)
(20,198)
(18,947)
EBITDA
(2,160)
(1,492)
(1,513)
EV/EBITDA
1.54
13.54
12.52
Interest
79
271
2
Interest/NOPBT